Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianping Yin

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2024
Genome of <i>Halimeda opuntia</i> reveals differentiation of subgenomes and molecular bases of multinucleation and calcification in algaeHao Zhang, Xin Wang, Meng Qu, et al.
The EMBO Journal|November 9, 2007
Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF bindingBrent A Appleton, Ping Wu, Janice Maloney, et al.
Journal of Medicinal Chemistry|September 21, 2017
Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer's DiseaseSnahel Patel, William J Meilandt, Rebecca I Erickson, et al.
Nature|April 15, 2026
Template-driven scaffolding of SCF<sup>FBXO42</sup> regulates PP2A degradationSebastien Coassolo, Nairie Michaelian, Timurs Maculins, et al.
Journal of Medicinal Chemistry|October 3, 2015
Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12)Snahel Patel, Seth F Harris, Paul Gibbons, et al.
Journal of Medicinal Chemistry|January 21, 2015
Discovery of highly potent, selective, and efficacious small molecule inhibitors of ERK1/2Li Ren, Jonas Grina, David Moreno, et al.
Cancer Cell|March 22, 2016
Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2Scott A Foster, Daniel M Whalen, Ayşegül Özen, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase InhibitorMalcolm P Huestis, Matthew R Durk, Charles Eigenbrot, et al.
Elife|June 26, 2019
Massive antibody discovery used to probe structure-function relationships of the essential outer membrane protein LptDKelly M Storek, Joyce Chan, Rajesh Vij, et al.
Science Advances|August 19, 2021
Seadragon genome analysis provides insights into its phenotype and sex determination locusMeng Qu, Yali Liu, Yanhong Zhang, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2024
Genome of <i>Halimeda opuntia</i> reveals differentiation of subgenomes and molecular bases of multinucleation and calcification in algaeHao Zhang, Xin Wang, Meng Qu, et al.
The EMBO Journal|November 9, 2007
Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF bindingBrent A Appleton, Ping Wu, Janice Maloney, et al.
Journal of Medicinal Chemistry|September 21, 2017
Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer's DiseaseSnahel Patel, William J Meilandt, Rebecca I Erickson, et al.
Nature|April 15, 2026
Template-driven scaffolding of SCF<sup>FBXO42</sup> regulates PP2A degradationSebastien Coassolo, Nairie Michaelian, Timurs Maculins, et al.
Journal of Medicinal Chemistry|October 3, 2015
Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12)Snahel Patel, Seth F Harris, Paul Gibbons, et al.
Journal of Medicinal Chemistry|January 21, 2015
Discovery of highly potent, selective, and efficacious small molecule inhibitors of ERK1/2Li Ren, Jonas Grina, David Moreno, et al.
Cancer Cell|March 22, 2016
Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2Scott A Foster, Daniel M Whalen, Ayşegül Özen, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase InhibitorMalcolm P Huestis, Matthew R Durk, Charles Eigenbrot, et al.
Elife|June 26, 2019
Massive antibody discovery used to probe structure-function relationships of the essential outer membrane protein LptDKelly M Storek, Joyce Chan, Rajesh Vij, et al.
Science Advances|August 19, 2021
Seadragon genome analysis provides insights into its phenotype and sex determination locusMeng Qu, Yali Liu, Yanhong Zhang, et al.
Pageof 14